TARGETED INFECTION OF A RETROVIRUS BEARING A CD4-ENV CHIMERA INTO HUMAN-CELLS EXPRESSING HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1

被引:30
作者
MATANO, T
ODAWARA, T
IWAMOTO, A
YOSHIKURA, H
机构
[1] UNIV TOKYO,FAC MED,DEPT BACTERIOL,BUNKYO KU,TOKYO 113,JAPAN
[2] UNIV TOKYO,INST MED SCI,DEPT INFECT DIS,MINATO KU,TOKYO 108,JAPAN
[3] NATL INST HLTH,AIDS RES CTR,SHINJUKU KU,TOKYO 162,JAPAN
[4] NATL INST HLTH,DIV MOLEC GENET,SHINJUKU KU,TOKYO 162,JAPAN
关键词
D O I
10.1099/0022-1317-76-12-3165
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
We constructed a hybrid Moloney murine leukaemia virus (MoMLV) bearing both a chimeric CD4 and the wild-type MoMLV envelope protein (Env) on its surface. The chimeric molecule, consisting of a surface domain of CD4 and the C-terminal two-thirds of MLV Env, was expressed on the cell surface. When expressed in MoMLV-infected cells, the CD4-Env chimera was incorporated into the virion as efficiently as the wildtype MoMLV Env. The hybrid MoMLV could infect human HeLa cells (although not with high efficiency) only if the cells were expressing human immunodeficiency virus type 1 genome. This method of ligand incorporation into a virion may lead to a development of a cell-specific retroviral vector for targeting gene therapy.
引用
收藏
页码:3165 / 3169
页数:5
相关论文
共 25 条
[1]   PRODUCTION OF ACQUIRED IMMUNODEFICIENCY SYNDROME-ASSOCIATED RETROVIRUS IN HUMAN AND NONHUMAN CELLS TRANSFECTED WITH AN INFECTIOUS MOLECULAR CLONE [J].
ADACHI, A ;
GENDELMAN, HE ;
KOENIG, S ;
FOLKS, T ;
WILLEY, R ;
RABSON, A ;
MARTIN, MA .
JOURNAL OF VIROLOGY, 1986, 59 (02) :284-291
[2]   CELLULAR PROTEINS BOUND TO IMMUNODEFICIENCY VIRUSES - IMPLICATIONS FOR PATHOGENESIS AND VACCINES [J].
ARTHUR, LO ;
BESS, JW ;
SOWDER, RC ;
BENVENISTE, RE ;
MANN, DL ;
CHERMANN, JC ;
HENDERSON, LE .
SCIENCE, 1992, 258 (5090) :1935-1938
[3]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[4]   ROLE OF THE MATRIX PROTEIN IN THE VIRION ASSOCIATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENVELOPE GLYCOPROTEIN [J].
DORFMAN, T ;
MAMMANO, F ;
HASELTINE, WA ;
GOTTLINGER, HG .
JOURNAL OF VIROLOGY, 1994, 68 (03) :1689-1696
[5]   OLIGOMERIC STRUCTURE OF A PROTOTYPE RETROVIRUS GLYCOPROTEIN [J].
EINFELD, D ;
HUNTER, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (22) :8688-8692
[6]   THE EFFICIENCY OF CELL TARGETING BY RECOMBINANT RETROVIRUSES DEPENDS ON THE NATURE OF THE RECEPTOR AND THE COMPOSITION OF THE ARTIFICIAL CELL-VIRUS LINKER [J].
ETIENNEJULAN, M ;
ROUX, P ;
CARILLO, S ;
JEANTEUR, P ;
PIECHACZYK, M .
JOURNAL OF GENERAL VIROLOGY, 1992, 73 :3251-3255
[7]   PROGRESS TOWARD HUMAN-GENE THERAPY [J].
FRIEDMANN, T .
SCIENCE, 1989, 244 (4910) :1275-1281
[8]   THE EFFECT OF SPECIFIC MUTATIONS AT AND AROUND THE GAG-POL GENE JUNCTION OF MOLONEY MURINE LEUKEMIA-VIRUS [J].
JONES, DS ;
NEMOTO, F ;
KUCHINO, Y ;
MASUDA, M ;
YOSHIKURA, H ;
NISHIMURA, S .
NUCLEIC ACIDS RESEARCH, 1989, 17 (15) :5933-5945
[9]   TISSUE-SPECIFIC TARGETING OF RETROVIRAL VECTORS THROUGH LIGAND-RECEPTOR INTERACTIONS [J].
KASAHARA, N ;
DOZY, AM ;
KAN, YW .
SCIENCE, 1994, 266 (5189) :1373-1376
[10]  
KOCH W, 1983, J VIROL, V45, P1